XRAY vs. WST
Compare and contrast key facts about DENTSPLY SIRONA Inc. (XRAY) and West Pharmaceutical Services, Inc. (WST).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: XRAY or WST.
Performance
XRAY vs. WST - Performance Comparison
Returns By Period
In the year-to-date period, XRAY achieves a -45.14% return, which is significantly lower than WST's -9.09% return. Over the past 10 years, XRAY has underperformed WST with an annualized return of -9.14%, while WST has yielded a comparatively higher 20.48% annualized return.
XRAY
-45.14%
-17.67%
-29.71%
-37.73%
-18.58%
-9.14%
WST
-9.09%
3.78%
-2.35%
-9.55%
16.61%
20.48%
Fundamentals
| XRAY | WST | |
|---|---|---|
| Market Cap | $3.88B | $23.16B |
| EPS | -$2.03 | $6.74 |
| PEG Ratio | 0.93 | 5.97 |
| Total Revenue (TTM) | $3.90B | $2.88B |
| Gross Profit (TTM) | $1.04B | $1.00B |
| EBITDA (TTM) | -$62.00M | $743.90M |
Key characteristics
| XRAY | WST | |
|---|---|---|
| Sharpe Ratio | -0.95 | -0.25 |
| Sortino Ratio | -1.12 | -0.09 |
| Omega Ratio | 0.81 | 0.99 |
| Calmar Ratio | -0.51 | -0.23 |
| Martin Ratio | -1.46 | -0.51 |
| Ulcer Index | 25.87% | 18.79% |
| Daily Std Dev | 39.67% | 38.54% |
| Max Drawdown | -73.68% | -55.52% |
| Current Drawdown | -70.74% | -31.76% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between XRAY and WST is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
XRAY vs. WST - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for DENTSPLY SIRONA Inc. (XRAY) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
XRAY vs. WST - Dividend Comparison
XRAY's dividend yield for the trailing twelve months is around 3.23%, more than WST's 0.25% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XRAY DENTSPLY SIRONA Inc. | 3.23% | 1.57% | 1.57% | 0.77% | 0.76% | 0.66% | 0.95% | 0.53% | 0.54% | 0.48% | 0.50% | 0.52% |
WST West Pharmaceutical Services, Inc. | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% | 0.77% | 0.78% |
Drawdowns
XRAY vs. WST - Drawdown Comparison
The maximum XRAY drawdown since its inception was -73.68%, which is greater than WST's maximum drawdown of -55.52%. Use the drawdown chart below to compare losses from any high point for XRAY and WST. For additional features, visit the drawdowns tool.
Volatility
XRAY vs. WST - Volatility Comparison
DENTSPLY SIRONA Inc. (XRAY) has a higher volatility of 34.53% compared to West Pharmaceutical Services, Inc. (WST) at 12.05%. This indicates that XRAY's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
XRAY vs. WST - Financials Comparison
This section allows you to compare key financial metrics between DENTSPLY SIRONA Inc. and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities